MIT IDs role of key protein in tumor growth

March 15, 2007

MIT researchers have identified how a missing protein causes tissue to become precancerous--a finding that could help doctors identify patients at high risk to develop tumors.

Most breast and prostate tumors are missing the protein, known as 14-3-3 sigma, but until now it has not been clear what role it plays in tumor growth. The MIT researchers report in the March 15 issue of Nature that when the protein is knocked down, dividing cells fail to separate fully and become precancerous.

"The cells try to divide and try to divide, and they just give up. They can't finish cytokinesis (the final stages of cell division)," said Michael Yaffe, associate professor of biology and biological engineering and leader of the research team. Failing to divide completely, the cells recombine into a single cell with two nuclei.

Such fused, or binucleate, cells have recently been shown to be precursors to cancer cells. They are often found in so-called "dysplastic" tissue, which consists of cells that are not fully normal but are not cancerous, said Yaffe.

Comparing tumors to weeds, Yaffe explained that those tissues act as fertile "soil" for tumor development. "Tumors grow in epithelial tissues that are already deranged for some reason, and something about that soil makes it better able to grow weeds," he said.

Loss of 14-3-3 sigma in dysplastic tissue could serve as a marker to help doctors predict whether tumors will develop. "Our hope is that it will be possible to monitor 14-3-3 expression in these 'benign' conditions, a subset of which may not be so benign," said Yaffe, who is also affiliated with MIT's Center for Cancer Research, the Broad Institute of MIT and Harvard, and Beth Israel Deaconess Medical Center.

The researchers were initially intrigued by the fact that 14-3-3 sigma is missing in normal tissue that surrounds tumors, which suggested that its function is lost very early in tumor development. Once the researchers started investigating the protein, they eventually unraveled a complex signaling pathway whose disruption leads to the failure of cell division.

They discovered that 14-3-3 sigma is most active during mitosis, when it helps control production of proteins necessary for division. Although 14-3-3 sigma interacts with many proteins, the research team focused on its relationship with a single protein, a translation factor known as eIF4B.

Translation factors are proteins that help determine the mix of proteins that a cell produces. Translation occurs when a messenger molecule known as mRNA carries information encoded by DNA to a cell organelle called the ribosome, which "translates" the mRNA sequence into a protein.

The translation factor eIF4B forms part of an enzyme that allows mRNA to unwind so the ribosome can read its sequence. When 14-3-3 sigma is knocked out, eIF4B is not produced, and mRNA for the protein p58 cannot be translated. p58 plays a critical role in the final splitting of one cell into two during mitosis, so when it is missing, the cells cannot fully divide.

When p58 function is restored, the cells resume normal division.

The work demonstrates the importance of studying translation factors and the cell signaling pathways that affect them, Yaffe said. Most research on gene regulation focuses on transcription factors, which control which DNA sequences are transcribed into mRNA, but now "we're at the beginning of understanding another wave of regulation," which takes place at the translation level, he said.

The lead author of the paper is former MIT postdoctoral fellow Erik Wilker. Other authors are Marcel van Vugt, a postdoctoral fellow at the Center for Cancer Research (CCR); Steven Artim of the CCR and MIT's Department of Biology; Paul Huang, a professor in the Harvard-MIT Division of Health Sciences and Technology and Department of Biological Engineering; Christian Petersen, a former MIT postdoctoral associate; Christian Reinhardt, a postdoctoral fellow in the CCR and biology; Yun Feng of the CCR and biology; MIT Institute Professor Phillip Sharp; Nahum Sonenberg of McGill University; and Forest White, an assistant professor of biological engineering.

Source: MIT

4.6 /5 (5 votes)  

Rank 4.6 /5 (5 votes)
Tags

Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Study finds that anti-diabetic medication can prevent the long-term effects of maternal obesity

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that show that short therapy with the anti-diabetic medication ...

Medicine & Health / Health

created 18 hours ago | popularity 5 / 5 (1) | comments 1

FDA-approved drug rapidly clears amyloid from the brain, reverses Alzheimer's symptoms in mice

Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, published in the journal Science, show t ...

Medicine & Health / Neuroscience

created Feb 09, 2012 | popularity 4.9 / 5 (51) | comments 20 | with audio podcast

Steroid injections prove effective in treatment of lumbar disc herniations

The use of epidural steroid injections may be a more efficient treatment option for lumbar disc herniations, according to research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in ...

Medicine & Health / Health

created 18 hours ago | popularity 5 / 5 (1) | comments 0

Amateur football players not always keen on returning to play after ACL injuries

Despite the known success rates of reconstructive Anterior Cruciate Ligament (ACL) surgery, the number of high school and collegiate football players returning to play may not be as high as anticipated, say researchers presenting ...

Medicine & Health / Health

created 18 hours ago | popularity not rated yet | comments 0

PRP treatment aids healing of elbow injuries say researchers

As elbow injuries continue to rise, especially in pitchers, procedures to help treat and get players back in the game quickly have been difficult to come by. However, a newer treatment called platelet rich plasma (PRP) may ...

Medicine & Health / Other

created 18 hours ago | popularity 5 / 5 (1) | comments 0


Walney offshore wind farm is world's biggest (for now)

(PhysOrg.com) -- The Walney wind farm on the Irish Sea--characterized by high tides, waves and windy weather--officially opened this week. The farm is treated in the press as a very big deal as the Walney ...

GPS court ruling leaves US phone tracking unclear

A US Supreme Court decision requiring a warrant to place a GPS device on the car of a criminal suspect leaves unresolved the bigger issue of police tracking using mobile phones, legal experts say.

Europeans protest controversial Internet pact

Tens of thousands of people marched in protests in more than a dozen European cities Saturday against a controversial anti-online piracy pact that critics say could curtail Internet freedom.

Europe stakes billion-dollar bet on new rocket

A pencil-slim rocket is scheduled to lift into space from South America on Monday, carrying a billion-dollar bet that Europe can grab a juicy slice of the market to place satellites in low orbit.

Netflix settlement trims 14 pct off 4Q earnings

(AP) -- Netflix pressed the rewind button on its fourth-quarter earnings after settling allegations that the video subscription service violated a consumer-privacy law.

Navy to begin tests on electromagnetic railgun prototype launcher

The Office of Naval Research (ONR)'s Electromagnetic (EM) Railgun program will take an important step forward in the coming weeks when the first industry railgun prototype launcher is tested at a facility ...